반응식
[CH3:1][C:2]([CH3:10])([CH3:9])[CH2:3][C@@H:4]([C:6]([OH:8])=O)[NH2:5].[Cl:11][C:12]1[CH:17]=[CH:16][C:15]([N:18]=[C:19]=[O:20])=[CH:14][CH:13]=1.[CH3:21][N:22]1[CH2:26][CH2:25][N:24]=[C:23]1[C:27]1[CH:32]=[CH:31][C:30]([NH2:33])=[CH:29][CH:28]=1.C(Cl)CCl>CN(C=O)C.O>[CH3:21][N:22]1[CH2:26][CH2:25][N:24]=[C:23]1[C:27]1[CH:32]=[CH:31][C:30]([NH:33][C:6](=[O:8])[CH:4]([CH2:3][C:2]([CH3:1])([CH3:10])[CH3:9])[NH:5][C:19]([NH:18][C:15]2[CH:16]=[CH:17][C:12]([Cl:11])=[CH:13][CH:14]=2)=[O:20])=[CH:29][CH:28]=1참가 물질
7
반응물 4
생성물 1
시약·촉매·용매 2
실험 절차
To a solution of DL-γ-methylleucine (48 mg, 0.33 mmol) in DMF (2 mL), 4-chlorophenyl isocyanate (50 mg, 0.33 mmol) was added. The mixture was then stirred at room temperature overnight. To the reaction mixture, 4-(1-Methyl-4,5-dihydro-1H-imidazol-2-yl)-phenylamine (150 mg, 0.86 mmol) and H2O (0.5 mL, to solubilize the amine) were added. To the solution, EDC (127 mg, 0.66 mmol) was added. After being stirred at room temperature overnight, the solution was concentrated in vacuo. The residue was purified by HPLC to give the titled compound as a powder (77 mg). MS 456.2 and 458.2 (M+H, Cl pattern).
후처리
- additionwere added
- stirringAfter being stirred at room temperature overnight
- concentrationthe solution was concentrated in vacuo
- customThe residue was purified by HPLC
출처 및 근거
- ORD 기록
- ord-a345ab8f0ba0495198f2a0545a6e7e11
- 출처 데이터셋
- uspto-grants-2010_03
- 특허 번호
- US07678913B2
연결된 노트
불러오는 중…